Dépistage du cancer de la prostate dans la population générale: des inconvénients certains, un bénéfice hypothétique

Anne Aupérin; Agnès Laplanche; Catherine Hill

doi:10.1016/j.lpm.2007.04.008

Dépistage du cancer de la prostate dans la population générale: des inconvénients certains, un bénéfice hypothétique

Anne Aupérin, Agnès Laplanche, Catherine Hill

Résultats de recherche: Contribution à un journal › Brève enquête › Revue par des pairs

10 Citations (Scopus)

Résumé

The main drawback of prostate cancer screening is overdiagnosis i.e. the detection of cancers that would never have become symptomatic; their treatment leads in many cases to impotence or urinary incontinence. Prostate cancer screening cannot be recommended at the present time because it has not yet been shown to reduce mortality from prostate cancer. The first results on mortality from 2 large trials of prostate cancer screening, conducted in Europe and in the United States, will not be available before 2008.

Titre traduit de la contribution	Prostate cancer screening in the general population: the drawbacks are certain but the benefits are hypothetical
langue originale	Français
Pages (de - à)	1045-1053
Nombre de pages	9
journal	Presse Medicale
Volume	36
Numéro de publication	7-8
Les DOIs	https://doi.org/10.1016/j.lpm.2007.04.008
état	Publié - 1 juil. 2007

Accès au document

10.1016/j.lpm.2007.04.008

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

@article{cc4b03f8f6ac46c3a94872ed3a267664,

title = "D{\'e}pistage du cancer de la prostate dans la population g{\'e}n{\'e}rale: des inconv{\'e}nients certains, un b{\'e}n{\'e}fice hypoth{\'e}tique",

abstract = "The main drawback of prostate cancer screening is overdiagnosis i.e. the detection of cancers that would never have become symptomatic; their treatment leads in many cases to impotence or urinary incontinence. Prostate cancer screening cannot be recommended at the present time because it has not yet been shown to reduce mortality from prostate cancer. The first results on mortality from 2 large trials of prostate cancer screening, conducted in Europe and in the United States, will not be available before 2008.",

author = "Anne Aup{\'e}rin and Agn{\`e}s Laplanche and Catherine Hill",

year = "2007",

month = jul,

day = "1",

doi = "10.1016/j.lpm.2007.04.008",

language = "Fran{\c c}ais",

volume = "36",

pages = "1045--1053",

journal = "Presse Medicale",

issn = "0755-4982",

number = "7-8",

}

TY - JOUR

T1 - Dépistage du cancer de la prostate dans la population générale

T2 - des inconvénients certains, un bénéfice hypothétique

AU - Aupérin, Anne

AU - Laplanche, Agnès

AU - Hill, Catherine

PY - 2007/7/1

Y1 - 2007/7/1

N2 - The main drawback of prostate cancer screening is overdiagnosis i.e. the detection of cancers that would never have become symptomatic; their treatment leads in many cases to impotence or urinary incontinence. Prostate cancer screening cannot be recommended at the present time because it has not yet been shown to reduce mortality from prostate cancer. The first results on mortality from 2 large trials of prostate cancer screening, conducted in Europe and in the United States, will not be available before 2008.

AB - The main drawback of prostate cancer screening is overdiagnosis i.e. the detection of cancers that would never have become symptomatic; their treatment leads in many cases to impotence or urinary incontinence. Prostate cancer screening cannot be recommended at the present time because it has not yet been shown to reduce mortality from prostate cancer. The first results on mortality from 2 large trials of prostate cancer screening, conducted in Europe and in the United States, will not be available before 2008.

UR - http://www.scopus.com/inward/record.url?scp=34347248740&partnerID=8YFLogxK

U2 - 10.1016/j.lpm.2007.04.008

DO - 10.1016/j.lpm.2007.04.008

M3 - Brève enquête

C2 - 17482419

AN - SCOPUS:34347248740

SN - 0755-4982

VL - 36

SP - 1045

EP - 1053

JO - Presse Medicale

JF - Presse Medicale

IS - 7-8

ER -